Jones, Philip G.

Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care

Spertus, J. A., Jones, P. G., Sandhu, A. T., & Arnold, S. V. (2020) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 619

Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire

Spertus, J. A., & Jones, P. G. (2015) · Circulation Cardiovascular Quality and Outcomes

Heart Failure Treatment and ManagementHealth Education and Validation

Cited by 491

Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk

Kosiborod, M., Inzucchi, S. E., Krumholz, H. M., Xiao, L., Jones, P. G., Fiske, S., Masoudi, F. A., Marso, S. P., & Spertus, J. A. (2008) · Circulation

Hyperglycemia and glycemic control in critically ill and hospitalized patientsAcute Myocardial Infarction Research

Cited by 385

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina

Kosiborod, M., Arnold, S. V., Spertus, J. A., McGuire, D. K., Li, Y., Yue, P., Ben-Yehuda, O., Katz, A., Jones, P. G., Olmsted, A., et al. (2013) · Journal of the American College of Cardiology

Heart rate and cardiovascular healthDiabetes Treatment and Management

Cited by 205

Comparable Performance of the Kansas City Cardiomyopathy Questionnaire in Patients With Heart Failure With Preserved and Reduced Ejection Fraction

Joseph, S. M., Novak, E., Arnold, S. V., Jones, P. G., Khattak, H., Platts, A. E., Dávila-Román, V. G., Mann, D. L., & Spertus, J. A. (2013) · Circulation: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 192

Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide

Pokharel, Y., Tang, F., Jones, P. G., Nambi, V., Bittner, V. A., Hira, R. S., Nasir, K., Chan, P. S., Maddox, T. M., Oetgen, W. J., et al. (2017) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthClinical practice guidelines implementation

Cited by 107

Health status after invasive or conservative care in coronary and advanced kidney disease

Spertus, J. A., Jones, P. G., Maron, D. J., Mark, D. B., O’Brien, S. M., Fleg, J. L., Reynolds, H. R., Stone, G. W., Sidhu, M. S., Chaitman, B. R., et al. (2020) · New England Journal of Medicine

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 84

Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention

Yeh, R. W., Normand, S.-L. T., Wolf, R. E., Jones, P. G., Ho, K. K. L., Cohen, D. J., Cutlip, D. E., Mauri, L., Kugelmass, A. D., Amin, A. P., et al. (2011) · Circulation

Coronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 63

Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids

Park, Y., Jones, P. G., & Harris, W. S. (2004) · The American Journal of Clinical Nutrition

Lipid metabolism and disordersFatty Acid Research and Health

Cited by 41

The prevalence and management of angina among patients with chronic coronary artery disease across US outpatient cardiology practices: insights from the Angina Prevalence and Provider Evaluation of Angina Relief ( APPEAR ) study

Kureshi, F., Shafiq, A., Arnold, S. V., Gosch, K., Breeding, T., Kumar, A. S., Jones, P. G., & Spertus, J. A. (2017) · Clinical Cardiology

Heart rate and cardiovascular healthCoronary Interventions and Diagnostics

Cited by 40

Association between cardiac rehabilitation participation and health status outcomes after acute myocardial infarction

Kureshi, F., Kennedy, K. F., Jones, P. G., Thomas, R. J., Arnold, S. V., Sharma, P., Fendler, T., Buchanan, D. M., Qintar, M., Ho, P. M., et al. (2016) · JAMA Cardiology

Cardiac Health and Mental HealthMedical Practices and Rehabilitation

Cited by 40

A Longer Course of Varenicline Therapy Improves Smoking Cessation Rates

Lee, J. H., Jones, P. G., Bybee, K., & O’Keefe, J. H. (2008) · Preventive Cardiology

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 34

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

Grodzinsky, A., Kosiborod, M., Tang, F., Jones, P. G., McGuire, D. K., Spertus, J. A., Beltrame, J. F., Jang, J.-S., Goyal, A., Butala, N. M., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 20

Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c

Arnold, S. V., McGuire, D. K., Spertus, J. A., Li, Y., Yue, P., Ben-Yehuda, O., Belardinelli, L., Jones, P. G., Olmsted, A., Chaitman, B. R., et al. (2014) · American Heart Journal

Heart rate and cardiovascular healthDiabetes Treatment and Management

Cited by 19

Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization)

Pokharel, Y., Jones, P. G., Graham, G., Collins, T., Regensteiner, J. G., Murphy, T. P., Cohen, D., Spertus, J. A., & Smolderen, K. (2018) · Circulation: Cardiovascular Quality and Outcomes

Peripheral Artery Disease ManagementLipoproteins and Cardiovascular Health

Cited by 6